Several antigens for example, eIF-4 gamma in lung cancer (Brass et al. 1997) and HER-2/neu in breast cancer (Scanlan et al. 2001), which are overexpressed and have mounted an immune response, have been identified by SEREX. This evidence concerns the gene ERBB2 and lung carcinoma.